Asset Management One’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Asset Management One’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-30,911	Closed	-$48K	–	1243
2016 Q3	$48K	Hold	30,911	–	–	﹤0.01%	1295
2016 Q2	$41K	Buy	+30,911	New	+$145K	﹤0.01%	1287
2015 Q4	–	Sell	-21,010	Closed	-$178K	–	1388
2015 Q3	$178K	Hold	21,010	–	–	﹤0.01%	1229
2015 Q2	$230K	Hold	21,010	–	–	﹤0.01%	1232
2015 Q1	$294K	Buy	+21,010	New	+$321K	﹤0.01%	1192

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Asset Management One's INFI Position: Q4 2016 in Review

Asset Management One sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2016, closing a stake of 30,911 shares — an estimated $48K sold.

Asset Management One first reported a position in INFI in Q1 2015 and held it in 5 quarters. The position peaked at $294K in Q1 2015. 94 funds tracked by Wall St. Rank hold INFI as of Q4 2016.

Asset Management One reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
Asset Management One sold 30,911 Infinity Pharmaceuticals, Inc. shares in Q4 2016, an estimated $48K.
Asset Management One first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2015 and held it in 5 quarters.
Asset Management One's Infinity Pharmaceuticals, Inc. position peaked at $294K in Q1 2015.
94 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2016.

Based on Asset Management One's 13F filing for Q4 2016, filed 13 Feb 2017.